Shelley Epstein

Shelley Epstein is an accomplished Healthcare Executive with over 30 years of commercial experience in global healthcare. She spearheaded multi-million dollar drug portfolios, launching over 10 new products into the market across multiple therapeutic domains, including Oncology, Metabolics, Neurosciences, Primary Care, Hospital and Specialty. With a proven track record in corporate and public affairs, government relations, marketing and pioneering initiatives for startups and fortune 500 companies, Shelley excels in business development, notably in groundbreaking realms like AI and genomics-based cancer testing.

Shelley has earned recognition for her work in forging innovative partnerships with government agencies, reflecting a profound understanding of public-private collaborations. Her global strategic vision has translated into commercialization plans designed for top tier markets like Canada, US, Europe and the Asia Pacific region. Beyond her professional achievements, she has contributed her expertise to various non-profit organizations in Alzheimer’s, Cancer, Diabetes and Neurodiverse populations. Shelley holds a Bachelor of Arts in Economics from McGill University and a Master of Science in Administration from Concordia University.